Zobrazeno 1 - 7
of 7
pro vyhledávání: '"drug therapy [Plaque, Amyloid]"'
Autor:
Martina Stazi, Sandra Lehmann, M. Sadman Sakib, Tonatiuh Pena-Centeno, Luca Büschgens, Andre Fischer, Sascha Weggen, Oliver Wirths
Publikováno v:
Cellular and Molecular Life Sciences
Cellular and molecular life sciences 79(1), 55 (2021). doi:10.1007/s00018-021-04062-8
Cellular and molecular life sciences 79(1), 55 (2021). doi:10.1007/s00018-021-04062-8
Epidemiological studies indicate that the consumption of caffeine, the most commonly ingested psychoactive substance found in coffee, tea or soft drinks, reduces the risk of developing Alzheimer’s disease (AD). Previous treatment studies with trans
Autor:
Tanja Blume, Severin Filser, Etienne Herzog, Jochen Herms, Mario M. Dorostkar, Finn Peters, Derya R. Shimshek, Nils Brose, Hazal Salihoglu, Eva Ferreira Rodrigues, Ulf Neumann
Publikováno v:
Acta Neuropathologica
Acta Neuropathologica, Springer Verlag, 2018, 135 (5), pp.695-710. ⟨10.1007/s00401-017-1804-9⟩
Acta Neuropathologica (Berl)
Acta neuropathologica 135(5), 695-710 (2018). doi:10.1007/s00401-017-1804-9
Acta Neuropathologica, Springer Verlag, 2018, 135 (5), pp.695-710. ⟨10.1007/s00401-017-1804-9⟩
Acta Neuropathologica (Berl)
Acta neuropathologica 135(5), 695-710 (2018). doi:10.1007/s00401-017-1804-9
BACE1 is the rate-limiting protease in the production of synaptotoxic β-amyloid (Aβ) species and hence one of the prime drug targets for potential therapy of Alzheimer’s disease (AD). However, so far pharmacological BACE1 inhibition failed to res
Autor:
Javier Rueda-Carrasco, Paula Garcia-Esparcia, Inmaculada Crespo, José A. Esteban, Juan Fortea, Pilar Esteve, José M. Valpuesta, Alberto Lleó, Guadalupe Pereyra, Estrella Gómez-Tortosa, María Jesús Martín-Bermejo, Isidro Ferrer, Mercedes Domínguez, Jonathan E. Draffin, Paola Bovolenta, Inmaculada Moreno, Daniel Alcolea, Alberto Rábano, Ester Aso, África Sandonís, Michael T. Heneka, María Inés Mateo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Nature reviews / Neuroscience 22(8), 1258-1268 (2019). doi:10.1038/s41593-019-0432-1
NATURE NEUROSCIENCE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Nature reviews / Neuroscience 22(8), 1258-1268 (2019). doi:10.1038/s41593-019-0432-1
NATURE NEUROSCIENCE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
The deposition of aggregated amyloid-β peptides derived from the pro-amyloidogenic processing of the amyloid precurson protein (APP) into characteristic amyloid plaques (APs) is distinctive to Alzheimer’s disease (AD). Alternative APP processing v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a0f9a5692c67f30d39b2f9105c61ff
http://hdl.handle.net/10261/193936
http://hdl.handle.net/10261/193936
Autor:
Hugo Vanderstichele, Derya R. Shimshek, Stephan A. Kaeser, Mathias Jucker, Juliane Schelle, Jens C. Göpfert, Matthias Staufenbiel, Erik Stoops, Eva-Maria Mandelkow, Lisa M. Häsler, Thomas O. Joos, Ulf Neumann
Publikováno v:
Alzheimer's and dementia 13(6), 701-709 (2017). doi:10.1016/j.jalz.2016.09.005
Alzheimer's and Dementia
Alzheimer's and Dementia
Introduction The inhibition of the β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a main therapeutic approach for the treatment of Alzheimer's disease (AD). We previously reported an age-related increase of tau protein in the cerebros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b80e3a98c39c265443e8e1638197c64
https://pub.dzne.de/record/139312
https://pub.dzne.de/record/139312
Autor:
Bernd Walbroel, Cathleen Lange, Björn Feistel, Toni Schumacher, Hans-Jochen Heinze, Timothy F. Sharbel, Sara Crockett, Jens Pahnke, Jacqueline Hofrichter, Markus Krohn
Publikováno v:
Current Alzheimer research 10(10), 1057-1069 (2013). doi:10.2174/15672050113106660171
Soluble β -amyloid peptides (A β) and small Aβ oligomers represent the most toxic peptide moieties recognized in brains affected by Alzheimer’s disease (AD). Here we provide the first evidence that specific St. John’s wort (SJW) extracts both
Autor:
Franz-Josef Gildehaus, Matthias Brendel, Janette Carlsen, Anna Jaworska, Peter Bartenstein, Christian Haass, Christina Rötzer, Thomas Luebbers, Johannes Trambauer, Harald Steiner, Johan Bylund, Paul Cumming, Karlheinz Baumann, Jochen Herms, Axel Rominger
Publikováno v:
Molecular psychiatry 20(10), 1179-1187 (2015). doi:10.1038/mp.2015.74
Molecular Psychiatry
Molecular Psychiatry
In a positron-emission tomography (PET) study with the β-amyloid (Aβ) tracer [(18)F]-florbetaben, we previously showed that Aβ deposition in transgenic mice expressing Swedish mutant APP (APP-Swe) mice can be tracked in vivo. γ-Secretase modulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a856cd45d5200ce586d07ac7fc141153
https://pub.dzne.de/record/138131
https://pub.dzne.de/record/138131
Autor:
D Quincy, K Quinn, EF Brigham, Tobias Bonhoeffer, Edith Winkler, Dale Schenk, Christian Haass, Harald Steiner, GS Basi, E Goldbach, Sabine Liebscher, Richard M. Page, K Käfer, Melanie Meyer-Luehmann, Mark Hübener
Publikováno v:
Molecular Psychiatry
Europe PubMed Central
Molecular psychiatry 19(8), 937-946 (2013). doi:10.1038/mp.2013.122
Europe PubMed Central
Molecular psychiatry 19(8), 937-946 (2013). doi:10.1038/mp.2013.122
The loss of synapses is a strong histological correlate of the cognitive decline in Alzheimer's disease (AD). Amyloid β-peptide (Aβ), a cleavage product of the amyloid precursor protein (APP), exerts detrimental effects on synapses, a process thoug